COMMUNIQUÉS West-GlobeNewswire

Project 55 Launches Free Mental Health First Responder Training for Public Use
11/06/2025
Evidence-informed course equips non-professionals to respond to mental health crises with practical, scalable skills Project 55 Logo LADERA RANCH, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Project 55, a nonprofit [...]
Moleculin Participates in Virtual Investor “What This Means” Segment
11/06/2025
Globally recognized Oncology Key Opinion Leader, Brian Andrew Van Tine, MD, PhD, discusses the positive topline results from the U.S. Phase 1B/2 clinical trial evaluating Annamycin for the treatment of Soft Tissue [...]
Capricor Therapeutics Announces Key Regulatory Updates for its Duchenne Muscular Dystrophy Program
11/06/2025
U.S. FDA successfully completed Pre-License Inspection; Company expects facility will meet all requirements to support licensure Advisory Committee meeting scheduled for July 30, 2025 Mid-cycle meeting recently [...]
Wandercraft announces Series D Round, bringing $75M in total funding secured for global acceleration of AI-powered robotics
11/06/2025
Clinical progress, industrial partnerships, and global recognition drive momentum in rehabilitation, personal mobility, and humanoid robotics. New agreement with Renault Group accelerates commercialization and advances [...]
Cabaletta Bio Announces Pricing of Public Offering of Securities
11/06/2025
PHILADELPHIA, June 11, 2025 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (“Cabaletta” or the “Company”) (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted [...]
Gapin Institute and Bauman Medical Announce Strategic Partnership – “Peak Launch: Personalized Longevity and Hair Optimization—powered by Gapin Institute for Bauman Medical”
11/06/2025
BOCA RATON, Fla. and SARASOTA, Fla., June 11, 2025 (GLOBE NEWSWIRE) -- The Gapin Institute for Precision Medicine, a global leader in longevity, and Bauman Medical, a global leader in hair restoration and scalp health, [...]
CLSI partners with LymeX Diagnostics Prize to support Phase 4 team advancing Lyme disease diagnostics
11/06/2025
MALVERN, Pa., June 11, 2025 (GLOBE NEWSWIRE) -- Clinical & Laboratory Standards Institute (CLSI) is proud to announce its partnership with LymeX Diagnostics Prize to support teams entering Phase 4 of the competition [...]
ACHC and BOC Partner to Support DMEPOS Suppliers Amid Market Changes
11/06/2025
CARY, N.C., June 11, 2025 (GLOBE NEWSWIRE) -- In response to recent regulatory developments, the Accreditation Commission for Health Care (ACHC) and the Board of Certification/Accreditation (BOC) have established a [...]
Centre for Neuro Skills Unveils New Website Design to Better Serve Brain Injury Patients and Their Families
11/06/2025
BAKERSFIELD, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Centre for Neuro Skills (CNS), a leader in traumatic brain injury and stroke rehabilitation services, today announced the launch of its completely redesigned [...]
LQpay Expands Compliant Surcharging Solution, Optimizing Payment Strategy for Healthcare Practices
11/06/2025
End-to-End Compliant Credit Surcharging with Custom Integration Now Available PLANTATION, Fla., June 11, 2025 (GLOBE NEWSWIRE) -- LQpay , a leading provider of innovative patient payments and automation technology, [...]
Spring Bio Solution Launches NCE Grid to decode Para IV Filing and First-to-File Opportunities
11/06/2025
SOMERSET, N.J., June 11, 2025 (GLOBE NEWSWIRE) -- Spring Bio Solution, a global leader in the comparator sourcing and clinical trial supplies , has launched NCE Grid , the world’s first free NCE-1 intelligence platform [...]
Basecamp Research Announces Breakthrough Discovery of Over One Million New Species, Yielding Enormous New Database Purpose-Built for Generative Foundation Models in Biology
11/06/2025
Company’s multi-year biodiscovery programme, driven by strategic economic partnerships across 26 countries, has resulted in BaseData TM , the largest and fastest growing database of new biological protein sequences - 9. [...]
Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress
11/06/2025
– 7 of 8 myositis patients achieved clinically meaningful TIS responses after discontinuation of all immunomodulators, while off or actively tapering steroids; responses were sustained throughout the follow-up period in [...]
Cabaletta Bio Announces Proposed Public Offering of Securities
11/06/2025
PHILADELPHIA, June 11, 2025 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (“Cabaletta” or the “Company”) (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted [...]
Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men’s Health Month
11/06/2025
Timed with National Men’s Health Month, the Prostate Monster ad campaign shines a light on quality-of-life issues associated with benign prostatic hyperplasia or BPH—a condition affecting millions of men 1 —and [...]
Telix Launches New Prostate Cancer Imaging Agent, Gozellix, in U.S.
11/06/2025
MELBOURNE, Australia and INDIANAPOLIS, June 11, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”) today announces that its next-generation PSMA-PET imaging 1 agent [...]
Corvus Pharmaceuticals Presents Soquelitinib Preclinical Data Highlighting Potential of ITK inhibition to Treat Systemic Sclerosis at EULAR 2025 Congress
11/06/2025
SOUTH SAN FRANCISCO, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced preclinical data highlighting the potential of [...]
Ligand Announces 2025 Investor Day in New York City
11/06/2025
JUPITER, Fla., June 11, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will host an Investor Day in New York City on Tuesday, December 9, 2025 at 10 a.m. Eastern Time [...]
Monopar and EDNOC Announce Expanded Access Program for MNPR-101-Zr and MNPR-101-Lu in Advanced Cancers
11/06/2025
WILMETTE, Ill. and HOUSTON, Texas, June 11, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar,” the “Company,” “us” and “our”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing [...]

Pages